Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Medulloblastoma × sonidegib × Clear all

Phase

Status

Completed 4 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Basal Cell Nevus Syndrome 2 Skin Neoplasms 1 Pancreatic Diseases 1 Multiple Myeloma 1 Medulloblastoma 1 Hematologic Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Basal Cell 1 Carcinoma 1

Interventions

Filgrastim 4 Topotecan 3 Melphalan 3 Granulocyte Colony-Stimulating Factor 3 Cyclophosphamide 3 etoposide phosphate 2 Vincristine 2 Thiotepa 2 Temozolomide 2 Radiotherapy 2 Mesna 2 Lomustine 2 Ifosfamide 2 Cisplatin 2 Carboplatin 2 Busulfan 2 sonidegib 1 sodium thiosulfate 1 silmitasertib 1 sargramostim 1 ribociclib 1 poly ICLC 1 palbociclib 1 gadobutrol 1 gadobenic acid 1 bempegaldesleukin 1 Yoga 1 Vaccines 1 TPI-287 1 Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04402073 2025-10-23

PersoMed-I

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡